Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SRPT |
---|---|---|
09:32 ET | 5976 | 127.73 |
09:34 ET | 100 | 127.35 |
09:36 ET | 700 | 126.89 |
09:39 ET | 1000 | 127.32 |
09:43 ET | 2600 | 127.55 |
09:45 ET | 1355 | 127.53 |
09:48 ET | 1407 | 127.28 |
09:50 ET | 2684 | 127.32 |
09:54 ET | 1700 | 126.21 |
09:56 ET | 654 | 126.41 |
09:57 ET | 2166 | 126.09 |
09:59 ET | 1575 | 126.03 |
10:01 ET | 1200 | 126.08 |
10:03 ET | 1181 | 126.385 |
10:06 ET | 8184 | 126.24 |
10:08 ET | 14839 | 126.765 |
10:10 ET | 443 | 126.79 |
10:12 ET | 100 | 127.095 |
10:15 ET | 1000 | 127.245 |
10:19 ET | 960 | 128.004 |
10:24 ET | 200 | 127.99 |
10:26 ET | 200 | 128 |
10:30 ET | 500 | 127.885 |
10:32 ET | 1042 | 127.63 |
10:33 ET | 2188 | 127.58 |
10:35 ET | 400 | 127.38 |
10:37 ET | 150 | 127.41 |
10:39 ET | 100 | 127.255 |
10:42 ET | 1100 | 127 |
10:44 ET | 805 | 127.06 |
10:46 ET | 100 | 127.24 |
10:48 ET | 100 | 127.085 |
10:50 ET | 900 | 127.125 |
10:53 ET | 576 | 127.08 |
10:55 ET | 1979 | 126.87 |
10:57 ET | 1668 | 126.575 |
11:00 ET | 1574 | 126.4 |
11:02 ET | 1813 | 126.63 |
11:04 ET | 589 | 126.4 |
11:06 ET | 700 | 126.67 |
11:08 ET | 400 | 126.57 |
11:09 ET | 936 | 126.59 |
11:11 ET | 301 | 126.665 |
11:13 ET | 400 | 126.59 |
11:15 ET | 500 | 126.64 |
11:18 ET | 500 | 126.84 |
11:20 ET | 300 | 126.95 |
11:22 ET | 1000 | 127.04 |
11:26 ET | 100 | 127.38 |
11:27 ET | 304 | 127.035 |
11:29 ET | 100 | 127.04 |
11:31 ET | 500 | 126.915 |
11:33 ET | 2425 | 126.72 |
11:36 ET | 637 | 126.82 |
11:38 ET | 1000 | 127.035 |
11:40 ET | 200 | 127.3 |
11:45 ET | 200 | 127.47 |
11:47 ET | 700 | 127.545 |
11:49 ET | 1296 | 127.29 |
11:51 ET | 700 | 127.41 |
11:54 ET | 100 | 127.355 |
11:56 ET | 640 | 127.25 |
11:58 ET | 100 | 127.24 |
12:00 ET | 200 | 127.285 |
12:02 ET | 345 | 127.29 |
12:03 ET | 1500 | 127.48 |
12:05 ET | 1314 | 127.48 |
12:07 ET | 800 | 127.5 |
12:09 ET | 200 | 127.34 |
12:12 ET | 1050 | 127.45 |
12:14 ET | 100 | 127.29 |
12:16 ET | 100 | 127.5 |
12:18 ET | 100 | 127.39 |
12:20 ET | 1100 | 127.32 |
12:21 ET | 1040 | 127.6 |
12:23 ET | 100 | 127.53 |
12:25 ET | 200 | 127.58 |
12:27 ET | 300 | 127.52 |
12:30 ET | 400 | 127.71 |
12:34 ET | 430 | 127.77 |
12:38 ET | 200 | 127.56 |
12:41 ET | 1274 | 127.56 |
12:43 ET | 469 | 127.545 |
12:45 ET | 100 | 127.49 |
12:48 ET | 100 | 127.6 |
12:50 ET | 659 | 127.38 |
12:52 ET | 400 | 127.29 |
12:54 ET | 500 | 127.31 |
12:56 ET | 724 | 127.36 |
12:57 ET | 100 | 127.325 |
12:59 ET | 400 | 127.4 |
01:01 ET | 358 | 127.44 |
01:03 ET | 515 | 127.49 |
01:06 ET | 200 | 127.465 |
01:10 ET | 400 | 127.4 |
01:12 ET | 1421 | 127.615 |
01:14 ET | 1010 | 127.415 |
01:15 ET | 200 | 127.4 |
01:17 ET | 1160 | 127.635 |
01:19 ET | 500 | 127.47 |
01:21 ET | 100 | 127.64 |
01:24 ET | 200 | 127.645 |
01:26 ET | 690 | 127.54 |
01:28 ET | 100 | 127.555 |
01:30 ET | 328 | 127.45 |
01:32 ET | 561 | 127.335 |
01:33 ET | 507 | 127.22 |
01:35 ET | 300 | 127.2 |
01:37 ET | 100 | 127.195 |
01:39 ET | 100 | 127.3399 |
01:42 ET | 200 | 127.15 |
01:44 ET | 200 | 127.22 |
01:46 ET | 200 | 127.3 |
01:48 ET | 1443 | 127.06 |
01:50 ET | 400 | 127.115 |
01:53 ET | 100 | 127.025 |
01:55 ET | 300 | 127.18 |
01:57 ET | 908 | 127.32 |
02:00 ET | 1200 | 127.36 |
02:02 ET | 500 | 127.345 |
02:06 ET | 100 | 127.35 |
02:08 ET | 400 | 127.45 |
02:09 ET | 650 | 127.5771 |
02:11 ET | 100 | 127.44 |
02:13 ET | 900 | 127.37 |
02:15 ET | 500 | 127.42 |
02:18 ET | 441 | 127.29 |
02:20 ET | 200 | 127.15 |
02:22 ET | 1103 | 127.25 |
02:24 ET | 400 | 127.195 |
02:26 ET | 1200 | 127.185 |
02:27 ET | 1000 | 127.12 |
02:29 ET | 1232 | 127.065 |
02:31 ET | 1534 | 126.89 |
02:33 ET | 100 | 126.945 |
02:36 ET | 700 | 126.905 |
02:38 ET | 1860 | 127.065 |
02:40 ET | 700 | 126.995 |
02:42 ET | 2100 | 126.7 |
02:44 ET | 100 | 126.7 |
02:45 ET | 412 | 126.81 |
02:47 ET | 200 | 126.68 |
02:49 ET | 500 | 126.73 |
02:51 ET | 600 | 126.71 |
02:54 ET | 597 | 126.825 |
02:58 ET | 400 | 126.78 |
03:00 ET | 1048 | 126.91 |
03:02 ET | 127 | 126.915 |
03:03 ET | 600 | 126.905 |
03:05 ET | 424 | 126.84 |
03:07 ET | 1100 | 126.87 |
03:09 ET | 637 | 126.82 |
03:12 ET | 207 | 126.9899 |
03:14 ET | 708 | 126.8975 |
03:18 ET | 1700 | 126.89 |
03:20 ET | 500 | 126.93 |
03:21 ET | 429 | 126.94 |
03:23 ET | 459 | 126.81 |
03:25 ET | 1000 | 126.885 |
03:27 ET | 594 | 126.69 |
03:30 ET | 740 | 126.61 |
03:32 ET | 5376 | 126.6 |
03:34 ET | 1037 | 126.585 |
03:36 ET | 2600 | 126.67 |
03:38 ET | 974 | 126.6525 |
03:39 ET | 497 | 126.815 |
03:41 ET | 3768 | 126.7 |
03:43 ET | 2817 | 126.775 |
03:45 ET | 2312 | 127.075 |
03:48 ET | 2181 | 127.01 |
03:50 ET | 1673 | 126.9 |
03:52 ET | 13740 | 126.91 |
03:54 ET | 3463 | 126.74 |
03:56 ET | 9900 | 126.43 |
03:57 ET | 10263 | 126.17 |
03:59 ET | 149695 | 126 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Sarepta Therapeutics Inc | 12.2B | 302.3x | --- |
Bio-Techne Corp | 12.1B | 72.8x | +11.13% |
Neurocrine Biosciences Inc | 12.6B | 36.3x | +62.04% |
Insmed Inc | 12.1B | -12.5x | --- |
Medpace Holdings Inc | 9.9B | 27.5x | +35.10% |
Exelixis Inc | 9.3B | 21.2x | -21.77% |
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 95.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $0.42 |
Book Value | $9.17 |
P/E Ratio | 302.3x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | 140.0x |
Operating Margin | 0.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.